Tag: Over-the-Counter Drugs and Devices

Displaying 1 - 20 of 50 results.

Pages

The Federal Trade Commission today announced a new “Enforcement Policy Statement on Marketing Claims for Over-the-Counter (OTC) Homeopathic Drugs.” The policy statement was informed by an FTC workshop held last year to examine how such drugs are marketed to consumers.
According to the FTC’s complaint, between June 2013 and October 2015 the defendants marketed and sold the “Doctor Trusted” seal and certification program to websites that primarily offered health-related products and services, such as dietary supplements.
CORRECTED The quote in this release has been updated for clarification. Viatek Consumer Products Group, Inc. and company owner and President Lou Lentine have agreed to settle Federal Trade Commission charges that they made deceptive claims for Viatek-brand Mosquito Shield Bands. The Commission...
Brief of the Federal Trade Commission urging the Third Circuit to reverse the district court’s summary judgment ruling, which held (1) that a brand-name drug manufacturer lacked monopoly power and (2) that product hopping almost never constitutes exclusionary conduct in any event....
The staff of the Federal Trade Commission has recommended that the U.S. Food and Drug Administration reconsider the framework it uses to regulate homeopathic medications because it may appear to conflict with the FTC’s advertising substantiation doctrine in ways that could harm consumers and cause...
The Federal Trade Commission has filed a joint complaint with the Florida Attorney General’s Office charging a New York-based operation known as Lifewatch with using blatantly illegal and deceptive robocalls to trick older consumers throughout the United States and Canada into signing up for...
FTC invites public to submit research, discussion topics, and requests to participate as panelists.
The Federal Trade Commission is mailing almost 500,000 checks totaling approximately $3 million to consumers who lost money to diet supplement marketers who made unsupported claims that their cactus-based fruit drink, Nopalea, would treat a variety of health problems.
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that personal care company Lornamead, Inc. deceived consumers with exaggerated claims that its “Lice Shield” shampoo, stick, and spray products will prevent or reduce the risk of getting...
Pharmaceutical company Prestige Brands Holdings, Inc., the maker of Dramamine, agreed to divest assets and marketing rights for the over-the-counter motion sickness drug Bonine to settle FTC charges that Prestige’s proposed acquisition of Insight Pharmaceuticals Corporation would...
The Quebec-based marketers of a supposed weight-loss treatment have agreed to pay  $500,000 to settle Federal Trade Commission charges that they deceived consumers with bogus claims that their Double Shot pills would cause rapid, substantial, and permanent weight loss, without diet or exercise.
The settlement with TriVita, Inc. is part of the FTC’s ongoing efforts to stop over-hyped health claims.
Cosmetics company L’Oréal USA, Inc. has agreed to settle Federal Trade Commission charges of deceptive advertising about its Lancôme Génifique and L’Oréal Paris Youth Code skincare products. According to the FTC’s complaint, L’Oréal made false and unsubstantiated claims that its Génifique and...
FTC’s most recent fraud study shows that more consumers were victims of fraudulent weight-loss claims than of any other specific fraud type covered by the survey.

Pages